Clover Health

We recently announced that nationwide, interoperable data exchange is not aspirational, it is achievable today. At #HIMSS26, CMS selected Clover Health to demo live on the mainstage. @kevinholub joined Amy Gleason to show it in action. In the workflow, @fastenhealth supports the patient application connecting to the network, @Kno2 securely routes patient-directed requests, @counterparthlth enables the exchange, and Clover responds as the payer. investors.cloverhealth.com/news-releases/…

We are proud to see @counterparthlth’s latest whitepaper highlight the impact of preventive intelligence at the point of care.

Proud to be part of the @Kno2 Connected™ ecosystem. Today at HIMSS 2026, Clover Health, @Kno2, and @counterparthlth are demonstrating our production-ready capability for real-time, patient-directed data exchange - showing how a patient request flows through the network and returns structured clinical and claims data. See it in action at #HIMSS26, Booth #12720. investors.cloverhealth.com/news-releases/…

Thanks to those who took the time to submit thoughtful questions for this quarter’s Supplemental Q&A. For Q425, we’ve answered a focused set of shareholder questions that we believe provide additional context on our performance in 2025, our priorities for 2026, and the longer-term trajectory of the business. These questions reflect submissions received through our shareholder portal, as well as recurring themes from recent conversations with investors and participants at industry conferences. Read more: investors.cloverhealth.com/static-files/8…

Today’s 4Q25 and FY 2025 earnings release reaffirms our ability to deliver strong MA performance and meaningful membership growth across a wide-network PPO, while continuing to lead the nation on HEDIS quality. Highlights: - We generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year. - We achieved industry-leading 2026 AEP growth of 53% year-over-year paired with strong returning member retention. - We expect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026. Read our full earnings release: investors.cloverhealth.com/static-files/7…

Best question we got this week: "I'm an accountant who builds custom picnic tables. Do you want me?" Did you improve on the design? Did you do something new (a new joint system that reuses scrap material. the most comfortable table ever. whatever!) - we want YOU. This isn’t for someone that just follows the path another person laid out. We're looking for product people, makers and builders. cloverhealth.com/commit

Clover Health Q4 and full-year 2025 earnings results are set for release on Thursday, February 26, 2026 with our accompanying CLOV Supplemental Q&A to go live the week after. Please submit all questions for CEO Andrew Toy and CFO Peter Kuipers via our IR website anytime between now and 4:30pm ET on Thursday, February 12. We look forward to hearing from you! Access our Q&A submissions form: forms.gle/9DkZDmuDKeqcxP…

Big news: we've grown our MA membership during AEP by 53%, increasing to ~153k members as of 1/1/26. Disciplined core-market growth, strong member retention & improving cohort economics establish a strong path to achieve first full-year GAAP Net Income profitability in 2026. @andrewtoy will present at #JPMHC26 tomorrow to discuss how these results fit into our longer-term strategy. Visit our investor website for more details and access via webcast. More on AEP: investors.cloverhealth.com/news-releases/…

Small Moments. Big Outcomes. Our new video shows how complete data and timely insights at the point of care can change a patient’s course of care. This is the future of value-based care. Read more about Counterpart’s 2025 results: investors.cloverhealth.com/news-releases/…

At Counterpart Health, we’re delivering measurable, sustained improvement in quality, risk, and total cost of care, starting with @CloverHealth and expanding rapidly to new clinicians.

We’re grateful to those who took the time to engage with us and submit thoughtful questions for this quarter’s Supplemental Q&A. This time around, we’ve answered a focused set of questions designed to offer deeper insight into our strategic direction. These questions were chosen from shareholder submissions as well as recurring themes from recent investor discussions and conferences. To continue the conversation, please email our investor relations team at investors@cloverhealth.com. Read more: investors.cloverhealth.com/static-files/e…

As reflected in today's earnings release, we generated positive Adjusted EBITDA profitability combined with growing membership by 35% and revenue by 39% for the year-to-date period. While our third quarter results were impacted by increased utilization and a higher-than-expected proportion of new members relative to returning member base, we anticipate that high coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care. Strong retention, above-market growth, and a larger cohort of profitable returning members position us for continued above-market growth, increasing profitability and improved positive FY26 financial results. Read more: investors.cloverhealth.com/static-files/5…

Our latest whitepaper highlights how PCP use of Counterpart Assistant (CA) technology is associated with earlier diagnosis and less frequent hospitalization in underserved populations. Learn more about how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease: investors.cloverhealth.com/news-releases/…

2026 Annual Enrollment Period is now open through 12/7 and we're pleased to offer high-choice PPO plans and HMO plans that deliver real results for seniors and physicians alike. More info: investors.cloverhealth.com/news-releases/…

Coming soon: Clover Health Q3 2025 earnings results are set for release on November 4, 2025. The week following earnings, our CEO Andrew Toy and CFO Peter Kuipers will continue the dialogue via our quarterly Q&A with CLOV shareholders. Please submit all inquiries via our Investor Relations website anytime between now and 4:30 pm ET on October 16, 2025. We appreciate your engagement and look forward to hearing from you! Access our Q&A submissions form here: forms.gle/vPevPMKG4nns7i…

Counterpart welcomes two new leaders to support growth and adoption of Counterpart Assistant for more partners, more clinicians, and more patients. New VP Blaine Lindsey will drive national enterprise growth while Gulf Region President Shannon Jacobs will scale operations in high-need markets. Read more: investors.cloverhealth.com/news-releases/…

Counterpart Assistant (CA) gets conversational. Our new generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care. Physicians can now ask CA questions about a patient’s medical history in natural language and receive immediate, cited responses within a PHI-safe environment, at no extra cost to eligible users. Read more: investors.cloverhealth.com/news-releases/…

A huge congratulations to Dr. Ian Duncan on his appointment as the 2025-2026 President-Elect and Vice-Chair of The Society of Actuaries! Clover has been privileged to benefit from Dr. Duncan's expertise and guidance as a member of our MA Board of Directors. His deep experience in predictive modeling and healthcare analytics continues to inform our approach to improving care for Medicare beneficiaries through technology and data-driven insights. Read more: investors.cloverhealth.com/news-releases/…